US Stock MarketDetailed Quotes

INDP Indaptus Therapeutics

Watchlist
  • 1.000
  • -0.045-4.31%
Close Nov 22 16:00 ET
  • 1.000
  • 0.0000.00%
Post 18:20 ET
10.20MMarket Cap-588P/E (TTM)

About Indaptus Therapeutics Company

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Company Profile

SymbolINDP
Company NameIndaptus Therapeutics
Listing DateAug 4, 2015
CEOMr. Jeffrey A. Meckler
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address3 Columbus Circle,15th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-646-427-2727
Websitehttp://indaptusrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey A. Meckler
  • Chief Executive Officer and Director
  • 1.00M
  • Dr. Michael J. Newman, PhD
  • Chief Scientific Officer and Director
  • 718.04K
  • Walt A. Linscott, Esq.
  • Chief Operating Officer
  • 770.04K
  • Roger J. Waltzman, M.D.
  • Chief Medical Officer
  • --
  • Nir Sassi
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
  • Chairman of the Board
  • 195.66K
  • Anthony J. Maddaluna
  • Independent Director
  • 87.14K
  • William Bradley Hayes
  • Independent Director
  • 90.03K
  • Dr. Robert E. Martell, M.D.,PhD
  • Independent Director
  • 79.67K
  • Hila Karah
  • Independent Director
  • 83.17K
  • Dr. Mark J. Gilbert, M.D.
  • Independent Director
  • 132.14K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data